Affiliations 

  • 1 Research Centre for Plant Conservation, Botanic Gardens and Forestry, National Research and Innovation Agency (BRIN), Cibinong, 16911 West Java, Indonesia
  • 2 Research Centre for Environmental and Clean Technology, National Research and Innovation Agency (BRIN), Kawasan Puspiptek Gedung 820, South Tangerang 15314, Indonesia
Trop Life Sci Res, 2024 Jul;35(2):87-106.
PMID: 39234478 DOI: 10.21315/tlsr2024.35.2.5

Abstract

Adlay is an edible high nutritious minor cereal. The research aimed to study the adlay performance when cultivated intercropped on young teak (Tectona grandis L.f.) plantation. The treatments were consisted of two factors that were arranged by factorial (3 × 3) in randomised completed block design with four replicates. The first factor was three fertilisation dosages of NPK (16-16-16), as 0 g/hole (F0), 2 g/hole (F2) and 4 g/hole (F4). The second factors were three planting space as 2 m × 2 m (PS2), 3 m × 3 m (PS3) and 4 m × 4 m (PS4). The parameter observed were vegetative growth which was consisted of plant height, the number of leaves, tillers and sub tillers, leaf chlorophyll content, grain production and biomass weight. The results revealed that fertilisation treatment were significantly affected the growth and production of adlay. On 12 weeks after planting, the F4 treatment produced the tallest plant, and the highest leaf number. The highest grain number/plant was achieved on the F2 treatment that was significantly different compared with the control (F0). The shading intensity due to the teak coverage significantly affected adlay growth and production. The PS4 treatment produced the highest number of leaves, tillers and grains. The combination of F2 and PS4 treatments resulted in the best growth and production. The PS2 treatment which has lower light intercepted by plants due to lower incident light intensity, resulting in a significant reduction in plant growth and production. It is suggested that adlay offers potency as a component of agro-forestry on the teak plantations.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.